125 related articles for article (PubMed ID: 24565892)
21. Unique features of primary sclerosing cholangitis in children.
Mieli-Vergani G; Vergani D
Curr Opin Gastroenterol; 2010 May; 26(3):265-8. PubMed ID: 20393280
[TBL] [Abstract][Full Text] [Related]
22. No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.
Wiencke K; Boberg KM; Donaldson P; Harbo H; Ling V; Schrumpf E; Spurkland A
Scand J Gastroenterol; 2006 May; 41(5):586-91. PubMed ID: 16638702
[TBL] [Abstract][Full Text] [Related]
23. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
24. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
25. Intestinal microbiota in primary sclerosing cholangitis.
Hov JR; Kummen M
Curr Opin Gastroenterol; 2017 Mar; 33(2):85-92. PubMed ID: 28030369
[TBL] [Abstract][Full Text] [Related]
26. Primary sclerosing cholangitis.
Karlsen TH; Schrumpf E; Boberg KM
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):655-66. PubMed ID: 20955968
[TBL] [Abstract][Full Text] [Related]
27. Will we ever model PSC? - "it's hard to be a PSC model!".
Pollheimer MJ; Trauner M; Fickert P
Clin Res Hepatol Gastroenterol; 2011 Dec; 35(12):792-804. PubMed ID: 21703962
[TBL] [Abstract][Full Text] [Related]
28. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LA; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
Melum E; Franke A; Schramm C; Weismüller TJ; Gotthardt DN; Offner FA; Juran BD; Laerdahl JK; Labi V; Björnsson E; Weersma RK; Henckaerts L; Teufel A; Rust C; Ellinghaus E; Balschun T; Boberg KM; Ellinghaus D; Bergquist A; Sauer P; Ryu E; Hov JR; Wedemeyer J; Lindkvist B; Wittig M; Porte RJ; Holm K; Gieger C; Wichmann HE; Stokkers P; Ponsioen CY; Runz H; Stiehl A; Wijmenga C; Sterneck M; Vermeire S; Beuers U; Villunger A; Schrumpf E; Lazaridis KN; Manns MP; Schreiber S; Karlsen TH
Nat Genet; 2011 Jan; 43(1):17-9. PubMed ID: 21151127
[TBL] [Abstract][Full Text] [Related]
31. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
Wiencke K; Spurkland A; Schrumpf E; Boberg KM
Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
[TBL] [Abstract][Full Text] [Related]
32. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
Henckaerts L; Jaspers M; Van Steenbergen W; Vliegen L; Fevery J; Nuytten H; Roskams T; Rutgeerts P; Cassiman JJ; Vermeire S; Cuppens H
J Hepatol; 2009 Jan; 50(1):150-7. PubMed ID: 18992954
[TBL] [Abstract][Full Text] [Related]
33. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis.
Moloney MM; Thomson LJ; Strettell MJ; Williams R; Donaldson PT
Hepatology; 1998 Sep; 28(3):660-2. PubMed ID: 9731555
[TBL] [Abstract][Full Text] [Related]
34. Update on primary sclerosing cholangitis.
Karlsen TH; Boberg KM
J Hepatol; 2013 Sep; 59(3):571-82. PubMed ID: 23603668
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.
Karlsen TH; Lie BA; Frey Frøslie K; Thorsby E; Broomé U; Schrumpf E; Boberg KM
Gastroenterology; 2006 Sep; 131(3):781-7. PubMed ID: 16952547
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.
Yang X; Cullen SN; Li JH; Chapman RW; Jewell DP
J Hepatol; 2004 Mar; 40(3):375-9. PubMed ID: 15123348
[TBL] [Abstract][Full Text] [Related]
37. Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis.
Han Y; Byun J; Zhu C; Sun R; Roh JY; Cordell HJ; Lee HS; Shaw VR; Kang SW; Razjouyan J; Cooley MA; Hassan MM; Siminovitch KA; Folseraas T; Ellinghaus D; Bergquist A; Rushbrook SM; Franke A; Karlsen TH; Lazaridis KN; ; McGlynn KA; Roberts LR; Amos CI
Nat Commun; 2023 Feb; 14(1):1069. PubMed ID: 36828809
[TBL] [Abstract][Full Text] [Related]
38. Gene expression by PBMC in primary sclerosing cholangitis: evidence for dysregulation of immune mediated genes.
Aoki CA; Dawson K; Kenny TP; Gershwin ME; Bowlus CL
Clin Dev Immunol; 2006; 13(2-4):265-71. PubMed ID: 17162367
[TBL] [Abstract][Full Text] [Related]
39. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
Bowlus CL; Karlsen TH; Broomé U; Thorsby E; Vatn M; Schrumpf E; Lie BA; Boberg KM
J Hepatol; 2006 Nov; 45(5):704-10. PubMed ID: 16750586
[TBL] [Abstract][Full Text] [Related]
40. An update on primary sclerosing cholangitis.
Maggs JR; Chapman RW
Curr Opin Gastroenterol; 2008 May; 24(3):377-83. PubMed ID: 18408468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
